You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: June 20, 2024

Investigational Drug Information for Fluoropyrimidine


✉ Email this page to a colleague

« Back to Dashboard


What is the development status for investigational drug Fluoropyrimidine?

Fluoropyrimidine is an investigational drug.

There have been 333 clinical trials for Fluoropyrimidine. The most recent clinical trial was a Phase 3 trial, which was initiated on May 5th 2019.

The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Eli Lilly and Company, and Hoffmann-La Roche.

There are seven hundred and fifty-one US patents protecting this investigational drug and seven international patents.

Recent Clinical Trials for Fluoropyrimidine
TitleSponsorPhase
Trastuzumab Deruxtecan(T-DXd) and Afatinib Combination in HER2-low Advanced Gastric CancerJeeyun LeePhase 1/Phase 2
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal CancerAffiliated Hospital of North Sichuan Medical CollegePhase 3
PD-1 Inhibitor Plus Chemotherapy With or Without Radiotherapy in Patients With Metastatic Esophageal CancerAnyang Tumor HospitalPhase 3

See all Fluoropyrimidine clinical trials

Clinical Trial Summary for Fluoropyrimidine

Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine

See all Fluoropyrimidine clinical trials

US Patents for Fluoropyrimidine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Fluoropyrimidine ⤷  Sign Up Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) ⤷  Sign Up
Fluoropyrimidine ⤷  Sign Up Combination therapies for cancer MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH) ⤷  Sign Up
Fluoropyrimidine ⤷  Sign Up Tapered looped suture Covidien LP (Mansfield, MA) ⤷  Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Fluoropyrimidine

Drugname Country Document Number Estimated Expiration Related US Patent
Fluoropyrimidine World Intellectual Property Organization (WIPO) WO2013071079 2031-11-09 ⤷  Sign Up
Fluoropyrimidine European Patent Office EP3003316 2033-05-31 ⤷  Sign Up
Fluoropyrimidine Spain ES2822665 2033-05-31 ⤷  Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.